MF
ABBV icon

MHI Funds’s AbbVie ABBV Stock Holding History

MHI Funds’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$1.05M Sell
13,751
-7,790
-36% -$664K 3.02% 15
2019
Q4 		$1.91M Sell
21,541
-1,315
-6% -$109K 2.43% 26
2019
Q3 		$1.73M Buy
+22,856
New +$1.57M 2.01% 29
2018
Q2 		– Sell
-25,947
Closed -$2.46M – 95
2018
Q1 		$2.46M Buy
25,947
+3
+0% +$330 2.13% 24
2017
Q4 		$2.51M Buy
+25,944
New +$2.45M 2.17% 26

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MHI Funds's ABBV Position: Q1 2020 in Review

MHI Funds reduced its AbbVie (ABBV) stake by 36% in Q1 2020, selling an estimated $664K and leaving 13,751 shares worth $1.05M. The position accounts for 3.02% of the portfolio, ranked #15.

MHI Funds first reported a position in ABBV in Q4 2017 and has held it in 5 quarters since. The position peaked at $2.51M in Q4 2017. 2,226 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

  • MHI Funds held 13,751 shares of AbbVie worth $1.05M as of Q1 2020.
  • MHI Funds sold 7,790 AbbVie shares in Q1 2020, an estimated $664K.
  • AbbVie made up 3.02% of MHI Funds's portfolio in Q1 2020, its #15 holding.
  • MHI Funds first reported a position in AbbVie in Q4 2017 and has held it in 5 quarters since.
  • MHI Funds's AbbVie position peaked at $2.51M in Q4 2017.
  • 2,226 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on MHI Funds's 13F filing for Q1 2020, filed 5 May 2020.